文献速递类风湿关节炎

美国退伍军人类风湿关节炎患者的前列腺癌风险

Risk of Prostate Cancer in US Veterans With Rheumatoid Arthritis.
PubMed 文献 · Arthritis Care Res (Hoboken) · 2022-11-18

该匹配队列研究纳入美国退伍军人健康管理局2000至2018年的56,514例类风湿关节炎(RA)男性患者与227,284例无RA男性患者,比较前列腺癌风险;校正混杂因素和VA医疗流失后,RA与前列腺癌风险轻度升高相关(校正HR 1.12,95%CI 1.04-1.20),但与前列腺癌死亡率无关(校正HR 0.92,95%CI 0.73-1.16)。

要点

  • RA患者前列腺癌发病率为3.50/1000人年,无RA患者为2.66/1000人年。
  • 校正混杂和VA医疗流失后,RA与前列腺癌风险轻度升高相关(校正HR 1.12,95%CI 1.04-1.20)。
  • RA与前列腺癌死亡率无关联(校正HR 0.92,95%CI 0.73-1.16)。

核心结论

  • 校正相关混杂因素和若干潜在偏倚来源后,RA与前列腺癌风险轻度升高相关,但与前列腺癌死亡率无关。
  • 即使极少的未测量混杂也可解释这些发现。

研究设计与样本

  • 在美国退伍军人健康管理局(VA)开展的匹配(最高1:5)队列研究。
  • 纳入2000至2018年男性RA患者与无RA患者,RA状态及协变量来自全国VA数据库。
  • 共纳入56,514例RA退伍军人和227,284例无RA退伍军人,随访2,337,104人年。
  • 前列腺癌通过链接的VA癌症数据库和国家死亡索引确定。
  • 采用多变量Cox模型比较两组前列腺癌风险,包括校正VA系统留存情况的模型。

主要发现

  • 随访期间共发生6,550例前列腺癌。
  • 前列腺癌发病率(每1000人年)在RA患者中为3.50(95%CI 3.32-3.69),在无RA患者中为2.66(95%CI 2.58-2.73)。
  • 校正混杂因素并对VA医疗流失进行删失后,RA与前列腺癌风险轻度升高相关(校正HR 1.12,95%CI 1.04-1.20)。
  • RA与前列腺癌死亡率无关联(校正HR 0.92,95%CI 0.73-1.16)。

局限性

  • 即使极少的未测量混杂也可解释这些发现。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Patients with rheumatoid arthritis (RA) have an increased risk of select cancers, including lymphoma and lung cancer. Whether RA influences prostate cancer risk is uncertain. We aimed to determine the risk of prostate cancer in patients with RA compared to patients without RA in the Veterans Health Administration (VA). METHODS: We performed a matched (up to 1:5) cohort study of male patients with and without RA in the VA from 2000 to 2018. RA status, as well as covariates, were obtained from national VA databases. Prostate cancer was identified through linked VA cancer databases and the National Death Index. Multivariable Cox models compared prostate cancer risk between patients with RA and patients without RA, including models that accounted for retention in the VA system. RESULTS: We included 56,514 veterans with RA and 227,284 veterans without RA. During 2,337,104 patient-years of follow-up, 6,550 prostate cancers occurred. Prostate cancer incidence (per 1,000 patient-years) was 3.50 (95% confidence interval [95% CI] 3.32-3.69) in patients with RA and 2.66 (95% CI 2.58-2.73) in patients without RA. After accounting for confounders and censoring for attrition of VA health care, RA was modestly associated with a higher prostate cancer risk (adjusted HR [HRadj ] 1.12 [95% CI 1.04-1.20]). There was no association between RA and prostate cancer mortality (HRadj 0.92 [95% CI 0.73-1.16]). CONCLUSION: RA was associated with a modestly increased risk of prostate cancer, but not prostate cancer mortality, after accounting for relevant confounders and several potential sources of bias. However, even minimal unmeasured confounding could explain these findings.

来源:Arthritis Care Res (Hoboken),查看原文。版权归原作者所有。

引用

  1. Wheeler AM, Roul P, Yang Y, et al. Risk of Prostate Cancer in US Veterans With Rheumatoid Arthritis. Arthritis Care Res (Hoboken). 2022. PMID: 35612872. doi:10.1002/acr.24890

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。